Skip to content
ApplyGive

Other ways to search: Events Calendar | UTHSC News

Recent Publications

Racial and Cardiovascular Risk Anomalies in CKD (RCAV) cohort

  1. Vancomycin-Associated Acute Kidney Injury in a Large Veteran Population.
    Gyamlani G, Potukuchi PK, Thomas F, Akbilgic O, Soohoo M, Streja E, Naseer A, Sumida K, Molnar MZ, Kalantar-Zadeh K, Kovesdy CP.Am J Nephrol. 2019;49(2):133-142. doi: 10.1159/000496484. Epub 2019 Jan 24. PMID: 30677750
  1. Constipation and risk of death and cardiovascular events.
    Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Atherosclerosis. 2019 Feb;281:114-120. doi: 10.1016/j.atherosclerosis.2018.12.021. Epub 2018 Dec 23. PMID: 30658186
  1. Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis.
    Rhee CM, Kovesdy CP, Ravel VA, Streja E, Sim JJ, You AS, Gatwood J, Amin AN, Molnar MZ, Nguyen DV, Kalantar-Zadeh K. J Ren Nutr. 2019 Mar;29(2):82-90. doi: 10.1053/j.jrn.2018.07.003. Epub 2018 Nov 15. PMID: 30448393
  1. Association of Chronic Insomnia With Mortality and Adverse Renal Outcomes. 
    Lu JL, Freire AX, Molnar MZ, Kalantar-Zadeh K, Kovesdy CP. Mayo Clin Proc. 2018 Nov;93(11):1563-1570. doi: 10.1016/j.mayocp.2018.05.032. PMID: 30392541
  1. Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease.
    Sumida K, Molnar MZ, Potukuchi PK, Hassan F, Thomas F, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Kidney Int. 2018 May;93(5):1207-1216. doi: 10.1016/j.kint.2017.11.025. Epub 2018 Mar 2. PMID: 29409725
  1. Changes in Albuminuria and Subsequent Risk of Incident Kidney Disease.
    Sumida K, Molnar MZ, Potukuchi PK, George K, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP.
    Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1941-1949. doi: 10.2215/CJN.02720317. Epub 2017 Sep 11. PMID: 28893924
  1. Heart Failure Increases the Risk of Adverse Renal Outcomes in Patients With Normal Kidney Function.
    George LK, Koshy SKG, Molnar MZ, Thomas F, Lu JL, Kalantar-Zadeh K, Kovesdy CP. Circ Heart Fail. 2017 Aug;10(8):e003825. doi: 10.1161/CIRCHEARTFAILURE.116.003825. PMID: 28765150
  1. Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome.
    Gyamlani G, Molnar MZ, Lu JL, Sumida K, Kalantar-Zadeh K, Kovesdy CP. Nephrol Dial Transplant. 2017 Jan 1;32(1):157-164. doi: 10.1093/ndt/gfw227. PMID: 28391310
  1. Association of Restless Legs Syndrome With Incident Parkinson's Disease.
    Szatmari S Jr, Bereczki D, Fornadi K, Kalantar-Zadeh K, Kovesdy CP, Molnar MZ. Sleep. 2017 Feb 1;40(2):zsw065. doi: 10.1093/sleep/zsw065. PMID: 28364505
  1. Constipation and Incident CKD.
    Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Matsushita K, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. J Am Soc Nephrol. 2017 Apr;28(4):1248-1258. doi: 10.1681/ASN.2016060656. Epub 2016 Nov 10. PMID: 28122944
  1. Radical versus partial nephrectomy, chronic kidney disease progression and mortality in US veterans.
    Streja E, Kalantar-Zadeh K, Molnar MZ, Landman J, Arah OA, Kovesdy CP. Nephrol Dial Transplant. 2018 Jan 1;33(1):95-101. doi: 10.1093/ndt/gfw358. PMID: 27798198
  1. Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease.
    Gosmanova EO, Mikkelsen MK, Molnar MZ, Lu JL, Yessayan LT, Kalantar-Zadeh K, Kovesdy CP. J Am Coll Cardiol. 2016 Sep 27;68(13):1375-1386. doi: 10.1016/j.jacc.2016.06.054. PMID: 27659458
  1. Racial Differences in Association of Serum Calcium with Mortality and Incident Cardio- and Cerebrovascular Events.
    Lu JL, Molnar MZ, Ma JZ, George LK, Sumida K, Kalantar-Zadeh K, Kovesdy CP. J Clin Endocrinol Metab. 2016 Dec;101(12):4851-4859. doi: 10.1210/jc.2016-1802. Epub 2016 Sep 15. PMID: 27631543
  1. Age, Race and Cardiovascular Outcomes in African American Veterans.
    Norris KC, Mensah GA, Boulware LE, Lu JL, Ma JZ, Streja E, Molnar MZ, Kalantar-Zadeh K, Kovesdy CP. Ethn Dis. 2016 Jul 21;26(3):305-14. doi: 10.18865/ed.26.3.305. PMID: 27440969
  1. Increased Risk of Incident Chronic Kidney Disease, Cardiovascular Disease, and Mortality in Patients With Diabetes With Comorbid Depression.
    Novak M, Mucsi I, Rhee CM, Streja E, Lu JL, Kalantar-Zadeh K, Molnar MZ, Kovesdy CP. Diabetes Care. 2016 Nov;39(11):1940-1947. doi: 10.2337/dc16-0048. Epub 2016 Jun 16. PMID: 27311494
  1. Pain and Kidney Function Decline and Mortality: A Cohort Study of US Veterans.
    Ravel V, Ahmadi SF, Streja E, Sosnov JA, Kovesdy CP, Kalantar-Zadeh K, Chen JLT. Am J Kidney Dis. 2016 Aug;68(2):240-246. doi: 10.1053/j.ajkd.2016.02.048. Epub 2016 Apr 20. PMID: 27108099
  1. Age and Outcomes Associated with BP in Patients with Incident CKD.
    Kovesdy CP, Alrifai A, Gosmanova EO, Lu JL, Canada RB, Wall BM, Hung AM, Molnar MZ, Kalantar-Zadeh K. Clin J Am Soc Nephrol. 2016 May 6;11(5):821-31. doi: 10.2215/CJN.08660815. Epub 2016 Apr 21. PMID: 27103623
  1. Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes.
    Gosmanov AR, Lu JL, Sumida K, Potukuchi PK, Rhee CM, Kalantar-Zadeh K, Molnar MZ, Kovesdy CP. J Hypertens. 2016 May;34(5):907-13. doi: 10.1097/HJH.0000000000000864. PMID: 26928222
  1. Association of Pre-Operative Albuminuria with Post-Operative Outcomes after Coronary Artery Bypass Grafting.
    George LK, Molnar MZ, Lu JL, Kalantar-Zadeh K, Koshy SK, Kovesdy CP. Sci Rep. 2015 Nov 9;5:16458. doi: 10.1038/srep16458. PMID: 26548590
  1. Impact of Non-Adherence on Renal and Cardiovascular Outcomes in US Veterans.
    Gosmanova EO, Molnar MZ, Alrifai A, Lu JL, Streja E, Cushman WC, Kalantar-Zadeh K, Kovesdy CP. Am J Nephrol. 2015;42(2):151-7. doi: 10.1159/000440685. Epub 2015 Sep 24. PMID: 26398170
  1. Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans.
    Kovesdy CP, Norris KC, Boulware LE, Lu JL, Ma JZ, Streja E, Molnar MZ, Kalantar-Zadeh K. Circulation. 2015 Oct 20;132(16):1538-48. doi: 10.1161/CIRCULATIONAHA.114.015124. Epub 2015 Sep 18. PMID: 26384521
  1. Association of incident restless legs syndrome with outcomes in a large cohort of US veterans.
    Molnar MZ, Lu JL, Kalantar-Zadeh K, Kovesdy CP. J Sleep Res. 2016 Feb;25(1):47-56. doi: 10.1111/jsr.12335. PMID: 26377112
  1. Acute Kidney Injury After Major Surgery: A Retrospective Analysis of Veterans Health Administration Data.
    Grams ME, Sang Y, Coresh J, Ballew S, Matsushita K, Molnar MZ, Szabo Z, Kalantar-Zadeh K, Kovesdy CP. Am J Kidney Dis. 2016 Jun;67(6):872-80. doi: 10.1053/j.ajkd.2015.07.022. Epub 2015 Sep 1. PMID: 26337133
  1. Association of age and BMI with kidney function and mortality: a cohort study.
    Lu JL, Molnar MZ, Naseer A, Mikkelsen MK, Kalantar-Zadeh K, Kovesdy CP. Lancet Diabetes Endocrinol. 2015 Sep;3(9):704-14. doi: 10.1016/S2213-8587(15)00128-X. Epub 2015 Jul 30. PMID: 26235959
  1. Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans.
    Molnar MZ, Mucsi I, Novak M, Szabo Z, Freire AX, Huch KM, Arah OA, Ma JZ, Lu JL, Sim JJ, Streja E, Kalantar-Zadeh K, Kovesdy CP. Thorax. 2015 Sep;70(9):888-95. doi: 10.1136/thoraxjnl-2015-206970. Epub 2015 Jun 2. PMID: 26038534
  1. Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans.
    Molnar MZ, Alhourani HM, Wall BM, Lu JL, Streja E, Kalantar-Zadeh K, Kovesdy CP. Hepatology. 2015 May;61(5):1495-502. doi: 10.1002/hep.27664. Epub 2015 Mar 20. PMID: 25529816
  1. Association of medical treatment nonadherence with all-cause mortality in newly treated hypertensive US veterans.
    Gosmanova EO, Lu JL, Streja E, Cushman WC, Kalantar-Zadeh K, Kovesdy CP. Hypertension. 2014 Nov;64(5):951-7. doi: 10.1161/HYPERTENSIONAHA.114.03805. Epub 2014 Aug 4. PMID: 25259744.

Therapeutic Interventions in Chronic Kidney Disease (TRI-CKD) study

  1. Incident Diuretic Use and Subsequent Risk of Bone Fractures: A Large Nationwide Observational Study of US Veterans.
    Sumida K, Shrestha P, Mallisetty Y, Surbhi S, Thomas F, Streja E, Kalantar-Zadeh K, Kovesdy CP.
    Mayo Clin Proc. 2024 Jun;99(6):913-926. doi: 10.1016/j.mayocp.2023.09.018. Epub 2024 Apr 4.
    PMID: 38573302

  2. Anti-Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease.
    Sumida K, Shrestha P, Mallisetty Y, Thomas F, Gyamlani G, Streja E, Kalantar-Zadeh K, Kovesdy CP.
    JAMA Netw Open. 2024 Apr 1;7(4):e246822. doi: 10.1001/jamanetworkopen.2024.6822.
    PMID: 38625700

  3. Association of iron therapy with incidence of chronic kidney disease.
    Shrestha P, Paul S, Sumida K, Thomas F, Surbhi S, Naser AM, Streja E, Rhee CM, Kalantar-Zadeh K, Kovesdy CP.
    Eur J Haematol. 2023 Dec;111(6):872-880. doi: 10.1111/ejh.14091. Epub 2023 Sep 5.
    PMID: 37668586

  4. Association of long-term aspirin use with kidney disease progression.
    Lu JL, Shrestha P, Streja E, Kalantar-Zadeh K, Kovesdy CP.
    Front Med (Lausanne). 2023 Dec 4;10:1283385. doi: 10.3389/fmed.2023.1283385. eCollection 2023.
    PMID: 38111701

  5. Association of oral iron replacement therapy with kidney failure and mortality in CKD patients.
    Paul S, Shrestha P, Sumida K, Thomas F, Surbhi S, Naser AM, Streja E, Rhee CM, Kalantar-Zadeh K, Kovesdy CP. 
    Clin Kidney J. 2023 Aug 9;16(11):2082-2090.

  6. Therapeutic Interventions in Chronic Kidney Disease (TRI-CKD) study
    Association of oral iron replacement therapy with kidney failure and mortality in CKD patients.
    Paul S, Shrestha P, Sumida K, Thomas F, Surbhi S, Naser AM, Streja E, Rhee CM, Kalantar-Zadeh K, Kovesdy CP.
    Clin Kidney J. 2023. https://doi.org/10.1093/ckj/sfad190

  7. Association of Uric Acid-Lowering Therapy With Incident Chronic Kidney Disease.
    Hassan W, Shrestha P, Sumida K, Thomas F, Sweeney PL, Potukuchi PK, Rhee CM, Streja E, Kalantar-Zadeh K, Kovesdy CP. JAMA Netw Open. 2022 Jun 1;5(6):e2215878. doi: 10.1001/jamanetworkopen.2022.15878. PMID: 35657621

Transition of Care in Chronic Kidney Disease (TC-CKD) cohort

  1. Change Over Time in Pre-End-Stage Renal Disease 24-Hour Urine Creatinine as Muscle Mass Surrogate and Post-End-Stage Renal Disease Mortality.
    Amin S, Wall BM, Thomas F, Kalantar-Zadeh K, Sumida K, Kovesdy CP.
    J Ren Nutr. 2024 Mar 20:S1051-2276(24)00050-5. doi: 10.1053/j.jrn.2024.03.002. Online ahead of print.
    PMID: 38513825

  2. Association of dyskalemias with short-term health care utilization in patients with advanced CKD.
    Dashputre AA, Gatwood J, Sumida K, Thomas F, Akbilgic O, Potukuchi PK, Obi Y, Molnar MZ, Streja E, Kalantar-Zadeh K, Kovesdy CP. J Manag Care Spec Pharm. 2021 Oct;27(10):1403-1415. doi: 10.18553/jmcp.2021.27.10.1403. PMID: 34595956

  3. Cannabis Use and Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease Transitioning to Dialysis.
    Potukuchi PK, Moradi H, Park F, Kaplan C, Thomas F, Dashputre AA, Sumida K, Molnar MZ, Gaipov A, Gatwood JD, Rhee C, Streja E, Kalantar-Zadeh K, Kovesdy CP. Cannabis Cannabinoid Res. 2021 Oct 1. doi: 10.1089/can.2021.0044. Online ahead of print. PMID: 34597156

  4. Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis.
    Dashputre AA, Sumida K, Thomas F, Gatwood J, Akbilgic O, Potukuchi PK, Obi Y, Molnar MZ, Streja E, Kalantar Zadeh K, Kovesdy CP. Am J Nephrol. 2021;52(7):539-547. doi: 10.1159/000516902. Epub 2021 Jul 21. PMID: 34289468 

  5. Laxative Use and Change in Estimated Glomerular Filtration Rate in Patients With Advanced Chronic Kidney Disease.
    Sumida K, Dashputre AA, Potukuchi PK, Thomas F, Obi Y, Molnar MZ, Gatwood JD, Streja E, Kalantar-Zadeh K, Kovesdy CP. J Ren Nutr. 2021 Jul;31(4):361-369. doi: 10.1053/j.jrn.2020.08.005. Epub 2020 Sep 18. PMID: 32952006
  1. Laxative use in patients with advanced chronic kidney disease transitioning to dialysis.
    Sumida K, Dashputre AA, Potukuchi PK, Thomas F, Obi Y, Molnar MZ, Gatwood JD, Streja E, Kalantar-Zadeh K, Kovesdy CP. Nephrol Dial Transplant. 2020 Oct 10:gfaa205. doi: 10.1093/ndt/gfaa205. Online ahead of print. PMID: 33035325
  1. Clinical Outcomes of Warfarin Initiation in Advanced Chronic Kidney Disease Patients With Incident Atrial Fibrillation.
    Agarwal MA, Potukuchi PK, Sumida K, Naseer A, Molnar MZ, George LK, Koshy SK, Streja E, Thomas F, Kalantar-Zadeh K, Kovesdy CP. JACC Clin Electrophysiol. 2020 Dec 14;6(13):1658-1668. doi: 10.1016/j.jacep.2020.06.036. Epub 2020 Sep 16. PMID: 33334444
  1. Laxative Use and Risk of Dyskalemia in Patients with Advanced CKD Transitioning to Dialysis.
    Sumida K, Dashputre AA, Potukuchi PK, Thomas F, Obi Y, Molnar MZ, Gatwood JD, Streja E, Kalantar-Zadeh K, Kovesdy CP. J Am Soc Nephrol. 2021 Feb 5;32(4):950-9. doi: 10.1681/ASN.2020081120. Online ahead of print. PMID: 33547216
  1. Predialysis Potassium Variability and Postdialysis Mortality in Patients With Advanced CKD.
    Dashputre AA, Potukuchi PK, Sumida K, Kar S, Obi Y, Thomas F, Molnar MZ, Streja E, Kalantar-Zadeh K, Kovesdy CP. Kidney Int Rep. 2021 Jan 14;6(2):366-380. doi: 10.1016/j.ekir.2020.11.022. eCollection 2021 Feb. PMID: 33615062 Free PMC article.
  1. Potassium Trajectories prior to Dialysis and Mortality following Dialysis Initiation in Patients with Advanced CKD.
    Dashputre AA, Sumida K, Potukuchi PK, Kar S, Obi Y, Thomas F, Molnar MZ, Streja E, Kalantar-Zadeh K, Kovesdy CP. Nephron. 2021;145(3):265-274. doi: 10.1159/000514294. Epub 2021 Mar 22. PMID: 33752200
  1. Association between Posttransplant Opioid Use and Immunosuppressant Therapy Adherence among Renal Transplant Recipients.
    Chisholm-Burns MA, Spivey CA, Potukuchi PK, Streja E, Kalantar-Zadeh K, Kovesdy CP, Molnar MZ. Nephron. 2020;144(7):321-330. doi: 10.1159/000507257. Epub 2020 May 20. PMID: 32434210
  1. Longer Predialysis ACEi/ARB Utilization Is Associated With Reduced Postdialysis Mortality.
    Gosmanova EO, Molnar MZ, Naseer A, Sumida K, Potukuchi P, Gaipov A, Wall BM, Thomas F, Streja E, Kalantar-Zadeh K, Kovesdy CP. Am J Med. 2020 Sep;133(9):1065-1073.e3. doi: 10.1016/j.amjmed.2020.03.037. Epub 2020 Apr 21. PMID: 32330490
  1. Machine Learning to Identify Dialysis Patients at High Death Risk.
    Akbilgic O, Obi Y, Potukuchi PK, Karabayir I, Nguyen DV, Soohoo M, Streja E, Molnar MZ, Rhee CM, Kalantar-Zadeh K, Kovesdy CP. Kidney Int Rep. 2019 Jun 22;4(9):1219-1229. doi: 10.1016/j.ekir.2019.06.009. eCollection 2019 Sep. PMID: 31517141
  1. Predialysis coronary revascularization and postdialysis mortality.
    Gaipov A, Molnar MZ, Potukuchi PK, Sumida K, Canada RB, Akbilgic O, Kabulbayev K, Szabo Z, Koshy SKG, Kalantar-Zadeh K, Kovesdy CP. J Thorac Cardiovasc Surg. 2019 Mar;157(3):976-983.e7. doi: 10.1016/j.jtcvs.2018.08.107. Epub 2018 Sep 27. PMID: 31431793
  1. Association of Continuation of Statin Therapy Initiated Before Transition to Chronic Dialysis Therapy With Mortality After Dialysis Initiation.
    Streja E, Gosmanova EO, Molnar MZ, Soohoo M, Moradi H, Potukuchi PK, Kalantar-Zadeh K, Kovesdy CP. JAMA Netw Open. 2018 Oct 5;1(6):e182311. doi: 10.1001/jamanetworkopen.2018.2311. PMID: 30646217
  1. Development and Validation of Prediction Scores for Early Mortality at Transition to Dialysis.
    Obi Y, Nguyen DV, Zhou H, Soohoo M, Zhang L, Chen Y, Streja E, Sim JJ, Molnar MZ, Rhee CM, Abbott KC, Jacobsen SJ, Kovesdy CP, Kalantar-Zadeh K. Mayo Clin Proc. 2018 Sep;93(9):1224-1235. doi: 10.1016/j.mayocp.2018.04.017. Epub 2018 Aug 10. PMID: 30104041
  1. Acute kidney injury following coronary revascularization procedures in patients with advanced CKD.
    Gaipov A, Molnar MZ, Potukuchi PK, Sumida K, Szabo Z, Akbilgic O, Streja E, Rhee CM, Koshy SKG, Canada RB, Kalantar-Zadeh K, Kovesdy CP. Nephrol Dial Transplant. 2019 Nov 1;34(11):1894-1901. doi: 10.1093/ndt/gfy178. PMID: 29986054
  1. Abrupt Decline in Kidney Function Precipitating Initiation of Chronic Renal Replacement Therapy.
    Kovesdy CP, Naseer A, Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Streja E, Heung M, Abbott KC, Saran R, Kalantar-Zadeh K. Kidney Int Rep. 2017 Dec 23;3(3):602-609. doi: 10.1016/j.ekir.2017.12.007. eCollection 2018 May. PMID: 29854967
  1. History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study.
    Molnar MZ, Eason JD, Gaipov A, Talwar M, Potukuchi PK, Joglekar K, Remport A, Mathe Z, Mucsi I, Novak M, Kalantar-Zadeh K, Kovesdy CP. Transpl Int. 2018 May;31(5):554-565. doi: 10.1111/tri.13127. Epub 2018 Feb 27. PMID: 29405487
  1. Association of Pre-ESRD Serum Calcium With Post-ESRD Mortality Among Incident ESRD Patients: A Cohort Study.
    Obi Y, Park C, Soohoo M, Sumida K, Hamano T, Rhee CM, Kovesdy CP, Kalantar-Zadeh K, Streja E. J Bone Miner Res. 2018 Jun;33(6):1027-1036. doi: 10.1002/jbmr.3391. Epub 2018 Mar 23. PMID: 29342320
  1. Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis.
    Sumida K, Diskin CD, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Rhee CM, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Am J Nephrol. 2017;46(5):397-407. doi: 10.1159/000484356. Epub 2017 Nov 7. PMID: 29130991
  1. Association of the frequency of pre-end-stage renal disease medical care with post-end-stage renal disease mortality and hospitalization.
    Lu JL, Molnar MZ, Sumida K, Diskin CD, Streja E, Siddiqui OA, Kalantar-Zadeh K, Kovesdy CP. Nephrol Dial Transplant. 2018 May 1;33(5):789-795. doi: 10.1093/ndt/gfx192. PMID: 29106625
  1. Pre-ESRD Depression and Post-ESRD Mortality in Patients with Advanced CKD Transitioning to Dialysis.
    Molnar MZ, Streja E, Sumida K, Soohoo M, Ravel VA, Gaipov A, Potukuchi PK, Thomas F, Rhee CM, Lu JL, Kalantar-Zadeh K, Kovesdy CP. Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1428-1437. doi: 10.2215/CJN.00570117. Epub 2017 Jul 5. PMID: 28679562
  1. Effect of Age on the Association of Vascular Access Type with Mortality in a Cohort of Incident End-Stage Renal Disease Patients.
    Saleh T, Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Gyamlani GG, Streja E, Kalantar-Zadeh K, Kovesdy CP. Nephron. 2017;137(1):57-63. doi: 10.1159/000477271. Epub 2017 May 18. PMID: 28514785
  1. Pre-ESRD Dementia and Post-ESRD Mortality in a Large Cohort of Incident Dialysis Patients.
    Molnar MZ, Sumida K, Gaipov A, Potukuchi PK, Fülöp T, Joglekar K, Lu JL, Streja E, Kalantar-Zadeh K, Kovesdy CP. Dement Geriatr Cogn Disord. 2017;43(5-6):281-293. doi: 10.1159/000471761. Epub 2017 Apr 28. PMID: 28448971
  1. Early Mortality Associated with Inpatient versus Outpatient Hemodialysis Initiation in a Large Cohort of US Veterans with Incident End-Stage Renal Disease.
    Arif FM, Sumida K, Molnar MZ, Potukuchi PK, Lu JL, Hassan F, Thomas F, Siddiqui OA, Gyamlani GG, Kalantar-Zadeh K, Kovesdy CP. Nephron. 2017;137(1):15-22. doi: 10.1159/000473704. Epub 2017 Apr 27. PMID: 28445893 
  1. Pre-end-stage renal disease visit-to-visit systolic blood pressure variability and post-end-stage renal disease mortality in incident dialysis patients.
    Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. J Hypertens. 2017 Sep;35(9):1816-1824. doi: 10.1097/HJH.0000000000001376. PMID: 28399042 
  1. Seasonal variations in transition, mortality and kidney transplantation among patients with end-stage renal disease in the USA.
    Obi Y, Kalantar-Zadeh K, Streja E, Rhee CM, Reddy UG, Soohoo M, Wang Y, Ravel V, You AS, Jing J, Sim JJ, Nguyen DV, Gillen DL, Saran R, Robinson B, Kovesdy CP. Nephrol Dial Transplant. 2017 May 1;32(5):907. doi: 10.1093/ndt/gfx049. PMID: 28371867 
  1. Blood Pressure Before Initiation of Maintenance Dialysis and Subsequent Mortality.
    Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Ravel VA, Soohoo M, Rhee CM, Streja E, Sim JJ, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Am J Kidney Dis. 2017 Aug;70(2):207-217. doi: 10.1053/j.ajkd.2016.12.020. Epub 2017 Mar 11. PMID: 28291617 
  1. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.
    Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Obi Y, Rhee CM, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Nephrol Dial Transplant. 2018 Feb 1;33(2):264-273. doi: 10.1093/ndt/gfw412. PMID: 28064159
  1. Association between vascular access creation and deceleration of estimated glomerular filtration rate decline in late-stage chronic kidney disease patients transitioning to end-stage renal disease.
    Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Ravel VA, Soohoo M, Rhee CM, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Nephrol Dial Transplant. 2017 Aug 1;32(8):1330-1337. doi: 10.1093/ndt/gfw220. PMID: 27242372
  1. Predialysis Cardiovascular Disease Medication Adherence and Mortality After Transition to Dialysis.
    Molnar MZ, Gosmanova EO, Sumida K, Potukuchi PK, Lu JL, Jing J, Ravel VA, Soohoo M, Rhee CM, Streja E, Kalantar-Zadeh K, Kovesdy CP. Am J Kidney Dis. 2016 Oct;68(4):609-618. doi: 10.1053/j.ajkd.2016.02.051. Epub 2016 Apr 12. PMID: 27084246 
  1. Association of Slopes of Estimated Glomerular Filtration Rate With Post-End-Stage Renal Disease Mortality in Patients With Advanced Chronic Kidney Disease Transitioning to Dialysis.
    Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Jing J, Ravel VA, Soohoo M, Rhee CM, Streja E, Kalantar-Zadeh K, Kovesdy CP. Mayo Clin Proc. 2016 Feb;91(2):196-207. doi: 10.1016/j.mayocp.2015.10.026. PMID: 26848002 Free PMC article.

Chronic Kidney Disease Prognosis Consortium (CKD-PC)

  1. Development and Validation of the American Heart Association's PREVENT Equations. 
    Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, Blaha MJ, Carson AP, Chang AR, Ciemins E, Go AS, Gutierrez OM, Hwang SJ, Jassal SK, Kovesdy CP, Lloyd-Jones DM, Shlipak MG, Palaniappan LP, Sperling L, Virani SS, Tuttle K, Neeland IJ, Chow SL, Rangaswami J, Pencina MJ, Ndumele CE, Coresh J; Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group.
    Circulation. 2024 Feb 6;149(6):430-449. doi: 10.1161/CIRCULATIONAHA.123.067626. Epub 2023 Nov 10.
    PMID: 37947085

  2. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
    Writing Group for the CKD Prognosis Consortium; Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Alencar de Pinho N, Anderson A, Appel LJ, Ärnlöv J, Azizi F, Bansal N, Bell S, Bilo HJG, Brunskill NJ, Carrero JJ, Chadban S, Chalmers J, Chen J, Ciemins E, Cirillo M, Ebert N, Evans M, Ferreiro A, Fu EL, Fukagawa M, Green JA, Gutierrez OM, Herrington WG, Hwang SJ, Inker LA, Iseki K, Jafar T, Jassal SK, Jha V, Kadota A, Katz R, Köttgen A, Konta T, Kronenberg F, Lee BJ, Lees J, Levin A, Looker HC, Major R, Melzer Cohen C, Mieno M, Miyazaki M, Moranne O, Muraki I, Naimark D, Nitsch D, Oh W, Pena M, Purnell TS, Sabanayagam C, Satoh M, Sawhney S, Schaeffner E, Schöttker B, Shen JI, Shlipak MG, Sinha S, Stengel B, Sumida K, Tonelli M, Valdivielso JM, van Zuilen AD, Visseren FLJ, Wang AY, Wen CP, Wheeler DC, Yatsuya H, Yamagata K, Yang JW, Young A, Zhang H, Zhang L, Levey AS, Gansevoort RT.
    JAMA. 2023 Oct 3;330(13):1266-1277. doi: 10.1001/jama.2023.17002.
    PMID: 37787795

  3. Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study.
    Mark PB, Carrero JJ, Matsushita K, Sang Y, Ballew SH, Grams ME, Coresh J, Surapaneni A, Brunskill NJ, Chalmers J, Chan L, Chang AR, Chinnadurai R, Chodick G, Cirillo M, de Zeeuw D, Evans M, Garg AX, Gutierrez OM, Heerspink HJL, Heine GH, Herrington WG, Ishigami J, Kronenberg F, Lee JY, Levin A, Major RW, Marks A, Nadkarni GN, Naimark DMJ, Nowak C, Rahman M, Sabanayagam C, Sarnak M, Sawhney S, Schneider MP, Shalev V, Shin JI, Siddiqui MK, Stempniewicz N, Sumida K, Valdivielso JM, van den Brand J, Yee-Moon Wang A, Wheeler DC, Zhang L, Visseren FLJ, Stengel B.
    Eur Heart J. 2023 Apr 1;44(13):1157-1166. doi: 10.1093/eurheartj/ehac825.
    PMID: 36691956

  4. The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts.
    Grams ME, Brunskill NJ, Ballew SH, Sang Y, Coresh J, Matsushita K, Surapaneni A, Bell S, Carrero JJ, Chodick G, Evans M, Heerspink HJL, Inker LA, Iseki K, Kalra PA, Kirchner HL, Lee BJ, Levin A, Major RW, Medcalf J, Nadkarni GN, Naimark DMJ, Ricardo AC, Sawhney S, Sood MM, Staplin N, Stempniewicz N, Stengel B, Sumida K, Traynor JP, van den Brand J, Wen CP, Woodward M, Yang JW, Wang AY, Tangri N.
    J Am Soc Nephrol. 2023 Mar 1;34(3):482-494. doi: 10.1681/ASN.0000000000000050. Epub 2023 Jan 26.
    PMID: 36857500

  5. Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without Diabetes.
    Grams ME, Brunskill NJ, Ballew SH, Sang Y, Coresh J, Matsushita K, Surapaneni A, Bell S, Carrero JJ, Chodick G, Evans M, Heerspink HJL, Inker LA, Iseki K, Kalra PA, Kirchner HL, Lee BJ, Levin A, Major RW, Medcalf J, Nadkarni GN, Naimark DMJ, Ricardo AC, Sawhney S, Sood MM, Staplin N, Stempniewicz N, Stengel B, Sumida K, Traynor JP, van den Brand J, Wen CP, Woodward M, Yang JW, Wang AY, Tangri N; CKD Prognosis Consortium, Chalmers J, Woodward M, Hsu CY, Ricardo AC, Anderson A, Rao P, Feldman H, Chang AR, Ho K, Green J, Kirchner HL, Bell S, Siddiqui M, Palmer C, Shalev V, Chodick G, Stengel B, Metzger M, Flamant M, Houillier P, Haymann JP, Stempniewicz N, Cuddeback J, Ciemins E, Kovesdy CP, Sumida K, Carrero JJ, Trevisan M, Elinder CG, Wettermark B, Kalra P, Chinnadurai R, Tollitt J, Green D, Coresh J, Ballew SH, Chang AR, Gansevoort RT, Grams ME, Gutierrez O, Konta T, Köttgen A, Levey AS, Matsushita K, Polkinghorne K, Schäffner E, Woodward M, Zhang L, Ballew SH, Chen J, Coresh J, Grams ME, Matsushita K, Sang Y, Surapaneni A, Woodward M. Diabetes Care. 2022 Sep 1;45(9):2055-2063. doi: 10.2337/dc22-0698. PMID: 35856507

  6. Including Measures of Chronic Kidney Disease to Improve Cardiovascular Risk Prediction by SCORE2 and SCORE2-OP.
    Matsushita K, Kaptoge S, Hageman SH, Sang Y, Ballew SH, Grams ME, Surapaneni A, Sun L, Arnlov J, Bozic M, Brenner H, Brunskill NJ, Chang AR, Chinnadurai R, Cirillo M, Correa A, Ebert N, Eckardt KU, Gansevoort RT, Gutierrez O, Hadaegh F, He J, Hwang SJ, Jafar TH, Jassal SK, Kayama T, Kovesdy CP, Landman GW, Levey AS, Lloyd-Jones DM, Major RW, Miura K, Muntner P, Nadkarni GN, Nowak C, Ohkubo T, Pena MJ, Polkinghorne KR, Sairenchi T, Schaeffner E, Schneider MP, Shalev V, Shlipak MG, Solbu MD, Stempniewicz N, Tollitt J, Valdivielso JM, van der Leeuw J, Wang AYM, Wen CP, Woodward M, Yamagishi K, Yatsuya H, Zhang L, Dorresteijn JA, Di Angelantonio E, Visseren FL, Pennells L, Coresh J; Chronic Kidney Disease Prognosis Consortium.
    Eur J Prev Cardiol. 2022 Aug 16:zwac176. doi: 10.1093/eurjpc/zwac176. Online ahead of print. PMID: 35972749

  7. Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium.
    Shin JI, Chang AR, Grams ME, Coresh J, Ballew SH, Surapaneni A, Matsushita K, Bilo HJG, Carrero JJ, Chodick G, Daratha KB, Jassal SK, Nadkarni GN, Nelson RG, Nowak C, Stempniewicz N, Sumida K, Traynor JP, Woodward M, Sang Y, Gansevoort RT; CKD Prognosis Consortium.
    Hypertension. 2021 Sep;78(4):1042-1052. doi: 10.1161/HYPERTENSIONAHA.121.17323. Epub 2021 Aug 9. PMID: 34365812

  8. Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets.
    Matsushita K, Jassal SK, Sang Y, Ballew SH, Grams ME, Surapaneni A, Arnlov J, Bansal N, Bozic M, Brenner H, Brunskill NJ, Chang AR, Chinnadurai R, Cirillo M, Correa A, Ebert N, Eckardt KU, Gansevoort RT, Gutierrez O, Hadaegh F, He J, Hwang SJ, Jafar TH, Kayama T, Kovesdy CP, Landman GW, Levey AS, Lloyd-Jones DM, Major RW, Miura K, Muntner P, Nadkarni GN, Naimark DM, Nowak C, Ohkubo T, Pena MJ, Polkinghorne KR, Sabanayagam C, Sairenchi T, Schneider MP, Shalev V, Shlipak M, Solbu MD, Stempniewicz N, Tollitt J, Valdivielso JM, van der Leeuw J, Wang AY, Wen CP, Woodward M, Yamagishi K, Yatsuya H, Zhang L, Schaeffner E, Coresh J. EClinicalMedicine. 2020 Oct 14;27:100552. doi: 10.1016/j.eclinm.2020.100552. eCollection 2020 Oct. PMID: 33150324 
  1. Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis: An Individual Participant-Based Meta-analysis.
    Sumida K, Nadkarni GN, Grams ME, Sang Y, Ballew SH, Coresh J, Matsushita K, Surapaneni A, Brunskill N, Chadban SJ, Chang AR, Cirillo M, Daratha KB, Gansevoort RT, Garg AX, Iacoviello L, Kayama T, Konta T, Kovesdy CP, Lash J, Lee BJ, Major RW, Metzger M, Miura K, Naimark DMJ, Nelson RG, Sawhney S, Stempniewicz N, Tang M, Townsend RR, Traynor JP, Valdivielso JM, Wetzels J, Polkinghorne KR, Heerspink HJL. Ann Intern Med. 2020 Sep 15;173(6):426-435. doi: 10.7326/M20-0529. Epub 2020 Jul 14. PMID: 32658569
  1. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD Chronic Kidney Disease Collaboration. Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13. PMID: 32061315 
  1. Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data.
    Grams ME, Sang Y, Ballew SH, Matsushita K, Astor BC, Carrero JJ, Chang AR, Inker LA, Kenealy T, Kovesdy CP, Lee BJ, Levin A, Naimark D, Pena MJ, Schold JD, Shalev V, Wetzels JFM, Woodward M, Gansevoort RT, Levey AS, Coresh J. J Am Soc Nephrol. 2019 Sep;30(9):1746-1755. doi: 10.1681/ASN.2019010008. Epub 2019 Jul 10. PMID: 31292199
  1. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.
    Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration. Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127. doi: 10.1016/S2213-8587(18)30313-9. Epub 2019 Jan 8. PMID: 30635225 
  1. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium.
    Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, Gutierrez OM, Hosseinpanah F, Iseki K, Kenealy T, Klein B, Kronenberg F, Lee BJ, Li Y, Miura K, Navaneethan SD, Roderick PJ, Valdivielso JM, Visseren FLJ, Zhang L, Gansevoort RT, Hallan SI, Levey AS, Matsushita K, Shalev V, Woodward M; CKD Prognosis Consortium (CKD-PC). BMJ. 2019 Jan 10;364:k5301. doi: 10.1136/bmj.k5301. PMID: 30630856 
  1. Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.
    Inker LA, Grams ME, Levey AS, Coresh J, Cirillo M, Collins JF, Gansevoort RT, Gutierrez OM, Hamano T, Heine GH, Ishikawa S, Jee SH, Kronenberg F, Landray MJ, Miura K, Nadkarni GN, Peralta CA, Rothenbacher D, Schaeffner E, Sedaghat S, Shlipak MG, Zhang L, van Zuilen AD, Hallan SI, Kovesdy CP, Woodward M, Levin A; CKD Prognosis Consortium. Am J Kidney Dis. 2019 Feb;73(2):206-217. doi: 10.1053/j.ajkd.2018.08.013. Epub 2018 Oct 19. PMID: 30348535 
  1. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442-1451.
    Chronic Kidney Disease Prognosis Consortium. Kidney Int. 2018 Nov;94(5):1025-1026. doi: 10.1016/j.kint.2018.08.009. PMID: 30348292 
  1. International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.
    Mok Y, Ballew SH, Bash LD, Bhatt DL, Boden WE, Bonaca MP, Carrero JJ, Coresh J, D'Agostino RB Sr, Elley CR, Fowkes FGR, Jee SH, Kovesdy CP, Mahaffey KW, Nadkarni G, Peterson ED, Sang Y, Matsushita K. J Am Heart Assoc. 2018 Jul 7;7(14):e008426. doi: 10.1161/JAHA.117.008426. PMID: 29982232 
  1. Risk Factors for Prognosis in Patients With Severely Decreased GFR.
    Evans M, Grams ME, Sang Y, Astor BC, Blankestijn PJ, Brunskill NJ, Collins JF, Kalra PA, Kovesdy CP, Levin A, Mark PB, Moranne O, Rao P, Rios PG, Schneider MP, Shalev V, Zhang H, Chang AR, Gansevoort RT, Matsushita K, Zhang L, Eckardt KU, Hemmelgarn B, Wheeler DC. Kidney Int Rep. 2018 Jan 11;3(3):625-637. doi: 10.1016/j.ekir.2018.01.002. eCollection 2018 May. PMID: 29854970 
  1. Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA, James MT, Heerspink HJL, Pollock CA, Stevens PE, Tamura MK, Tonelli MA, Wheeler DC, Winkelmayer WC, Cheung M, Hemmelgarn BR; Conference Participants. Kidney Int. 2018 Jun;93(6):1281-1292. doi: 10.1016/j.kint.2018.02.006. Epub 2018 Apr 12. PMID: 29656903 
  1. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.
    Kovesdy CP, Matsushita K, Sang Y, Brunskill NJ, Carrero JJ, Chodick G, Hasegawa T, Heerspink HL, Hirayama A, Landman GWD, Levin A, Nitsch D, Wheeler DC, Coresh J, Hallan SI, Shalev V, Grams ME; CKD Prognosis Consortium. Eur Heart J. 2018 May 1;39(17):1535-1542. doi: 10.1093/eurheartj/ehy100. PMID: 29554312 
  1. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data.
    Matsushita K, Ballew SH, Coresh J, Arima H, Ärnlöv J, Cirillo M, Ebert N, Hiramoto JS, Kimm H, Shlipak MG, Visseren FLJ, Gansevoort RT, Kovesdy CP, Shalev V, Woodward M, Kronenberg F; Chronic Kidney Disease Prognosis Consortium. Lancet Diabetes Endocrinol. 2017 Sep;5(9):718-728. doi: 10.1016/S2213-8587(17)30183-3. Epub 2017 Jul 14. PMID: 28716631 
  1. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.
    Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K; CKD Prognosis Consortium. JAMA. 2016 Jan 12;315(2):164-74. doi: 10.1001/jama.2015.18202. PMID: 26757465 
  1. Past Decline Versus Current eGFR and Subsequent ESRD Risk.
    Kovesdy CP, Coresh J, Ballew SH, Woodward M, Levin A, Naimark DM, Nally J, Rothenbacher D, Stengel B, Iseki K, Matsushita K, Levey AS; CKD Prognosis Consortium. J Am Soc Nephrol. 2016 Aug;27(8):2447-55. doi: 10.1681/ASN.2015060687. Epub 2015 Dec 11. PMID: 26657867 
  1. Past Decline Versus Current eGFR and Subsequent Mortality Risk.
    Naimark DM, Grams ME, Matsushita K, Black C, Drion I, Fox CS, Inker LA, Ishani A, Jee SH, Kitamura A, Lea JP, Nally J, Peralta CA, Rothenbacher D, Ryu S, Tonelli M, Yatsuya H, Coresh J, Gansevoort RT, Warnock DG, Woodward M, de Jong PE; CKD Prognosis Consortium. J Am Soc Nephrol. 2016 Aug;27(8):2456-66. doi: 10.1681/ASN.2015060688. Epub 2015 Dec 11. PMID: 26657865 
  1. Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.
    Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX; Chronic Kidney Disease Prognosis Consortium. N Engl J Med. 2016 Feb 4;374(5):411-21. doi: 10.1056/NEJMoa1510491. Epub 2015 Nov 6. PMID: 26544982 
  1. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury.
    James MT, Grams ME, Woodward M, Elley CR, Green JA, Wheeler DC, de Jong P, Gansevoort RT, Levey AS, Warnock DG, Sarnak MJ; CKD Prognosis Consortium. Am J Kidney Dis. 2015 Oct;66(4):602-12. doi: 10.1053/j.ajkd.2015.02.338. Epub 2015 May 11. PMID: 25975964 
  1. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury.
    Grams ME, Sang Y, Ballew SH, Gansevoort RT, Kimm H, Kovesdy CP, Naimark D, Oien C, Smith DH, Coresh J, Sarnak MJ, Stengel B, Tonelli M; CKD Prognosis Consortium. Am J Kidney Dis. 2015 Oct;66(4):591-601. doi: 10.1053/j.ajkd.2015.02.337. Epub 2015 May 2. PMID: 25943717
  1. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.
    Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS. JAMA. 2014 Jun 25;311(24):2518-2531. doi: 10.1001/jama.2014.6634. PMID: 24892770

UT-DaVita Hemodialysis cohort

  1. Association of DNA methylation signatures with premature ageing and cardiovascular death in patients with end-stage kidney disease: a pilot epigenome-wide association study.
    Sumida K, Mozhui K, Liang X, Mallisetty Y, Han Z, Kovesdy CP.
    Epigenetics. 2023 Dec;18(1):2214394. doi: 10.1080/15592294.2023.2214394.
    PMID: 37207321 

  2. Circulating microRNA Profiles for Premature Cardiovascular Death in Patients with Kidney Failure with Replacement Therapy.
    Kuscu C, Mallisetty Y, Naik S, Han Z, Berta CJ, Kuscu C, Kovesdy CP, Sumida K.
    J Clin Med. 2023 Jul 30;12(15):5010. doi: 10.3390/jcm12155010.
    PMID: 37568412

  3. Circulating Microbial Signatures and Cardiovascular Death in Patients With ESRD.
    Sumida K, Pierre JF, Han Z, Mims TS, Potukuchi PK, Yuzefpolskaya M, Colombo PC, Demmer RT, Datta S, Kovesdy CP.
    Kidney Int Rep. 2021 Aug 4;6(10):2617-2628. doi: 10.1016/j.ekir.2021.07.023. eCollection 2021 Oct. PMID: 34622101

  4. Association between Nrf2 and CDKN2A expression in patients with end-stage renal disease: a pilot study.
    Sumida K, Han Z, Dashputre AA, Potukuchi PK, Kovesdy CP. Aging (Albany NY). 2020 Jul 13;12. doi: 10.18632/aging.103685. Online ahead of print. PMID: 32661200

  5. Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease.
    Han Z, Xiao Z, Kalantar-Zadeh K, Moradi H, Shafi T, Waikar SS, Quarles LD, Yu Z, Tin A, Coresh J, Kovesdy CP. Diagnostics (Basel). 2018 Oct 8;8(4):71. doi: 10.3390/diagnostics8040071. PMID: 30297602 

Sep 9, 2024